Identifying Parents in Child Welfare Services Who Need Mental Health Support: Depression and Anxiety Symptoms

September 16, 2024 updated by: Martin Forster, Karolinska Institutet

Identifying Parents in Child Welfare Services Who Need Mental Health Support: Depression and Anxiety Symptoms and Associated Factors

The main aim of this study is to examine the occurrence of mental health symptoms among parents referred to the Swedish child welfare services for child maltreatment and other family related risks. Additionally, to examine any variables associated with parents' levels of depression and anxiety.

Parents will respond to questionnaires administered by social workers. The level of depression and anxiety will be descriptively and statistically compared to clinical and normative samples. Additionally, statistical analyses will examine variables associated with parents' mental health symptoms.

Study Overview

Status

Not yet recruiting

Detailed Description

BACKGROUND:

Parental mental illness is associated with various family-related risks, including child maltreatment and children developing own psychiatric conditions. Studies indicate that parental mental illness is more prevalent in families into contact with the child welfare system due to child maltreatment or other risk conditions. However, there is a lack of studies that routinely examine the well-being of parents reported for child maltreatment. Furthermore, there is limited knowledge of whether the severity of parental symptoms varies based on the reasons for the child welfare report.

PURPOSE AND RESEARCH QUESTIONS:

The main aim of this study is to assess the occurrence of mental health symptoms among parents referred to the child welfare services (CWS) and whether any factors are associated with the level of symptoms. The research questions are:

  1. Is the average level of depression and anxiety among parents reported to CWS different from that in normative and clinical populations?
  2. Are parent and family characteristics, the reason for the child welfare involvement, or previous involvement with CWS associated with parents' levels of depression and anxiety?

METHODS:

This is a cross-sectional study using data collected within a feasibility study of the Collaboration-Screening-Referral model (in Swedish: Samverkan-Screening-Hänvisning - SSH) - an approach to screen parents for symptoms of mental illness using structured questionnaires, establish intra-agency collaboration, and refer to mental health services. An evaluation of the effects, feasibility and experiences of the SSH-model is presented in a separate study: "Screening to Identify Parents in Need of Mental Health Support: A Feasibility Study in Child Welfare Services". The present study presents data from the questionnaire administered to parents.

CWS agencies in Swedish municipalities will be recruited to take part in the research project. Social workers will receive training in employing screening for depression and anxiety. Then, they will administer a questionnaire measuring symptoms of depression and anxiety to parents they meet as a part of routine work. They will be encouraged to present the screening to every eligible parent they meet. When parents have responded to questionnaires, it is followed by a discussion about well-being and support needs. When relevant, the social worker provides information about what mental health support is available.

Parents' data will be anonymous. The multiple-choice questions will be restricted and phrased in a way that prevents identification. The survey will be made available in several languages.

SAMPLE SIZE CALCULATION AND ANALYSES:

Mean values from the instruments will be presented descriptively. Also, compared statistically (using t-test or ANOVA) to established cut-off values/clinical samples as well as data from parents in the general population. To take account of possible nesting effects resulting of parents from the same families responding, the alpha will conservatively be set to 0.025. At least 290 participants are needed for an 80% power (alpha = 0.025) to detect a small mean difference (d = 0.20). Additionally, multiple linear regression analyses will examine variables associated with parents' symptoms.

Study Type

Observational

Enrollment (Estimated)

290

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Parents reported to the social services due to concerns of the child's well-being.

Description

Inclusion Criteria:

  • A parental role in relation to a child 0-17 years old (the participant does not be a guardian or biological parent, can also be, for example, a partner to a parent).
  • A child welfare report has been filed for the child or the parent has reached out to the CWS themselves.

Exclusion Criteria:

  • Not able to read questionnaire in any available language and interpreter not available at the social services.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Parents reported to the child welfare services
Adults who are into contact with the Swedish CWS due to a child welfare report. The adults have a parental role in relation to a child 0-17 years old (referred to as 'parents').
Parents respond to questionnaires assessing depression and anxiety.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The Patient Health Questionnaire
Time Frame: At inclusion, each participant will be assessed one time only.
The Patient Health Questionnaire (PHQ-9) will be used to assess depressive symptoms, including suicidal ideation, over the last two weeks (9 questions). Items are scored 0-3, resulting in a total score of 0-27. Higher scores indicate more symptoms of depression.
At inclusion, each participant will be assessed one time only.
The GAD-7
Time Frame: At inclusion, each participant will be assessed one time only.
The 7-item GAD-7 will measure symptoms of anxiety. Items are scored 0-3, resulting in a total score of 0-21. Higher scores indicate more symptoms of anxiety.
At inclusion, each participant will be assessed one time only.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Parents' background
Time Frame: At inclusion, each participant will be assessed one time only.
Parent will respond to a few questions about their background when responding to the screening questionnaire.
At inclusion, each participant will be assessed one time only.
Parents' contact with mental health services
Time Frame: At inclusion, each participant will be assessed one time only.
In the screening questionnaire, parents will be asked whether they are currently or have previously been in contact with healthcare services for their mental health.
At inclusion, each participant will be assessed one time only.
Characteristics of the contact with child welfare services
Time Frame: At inclusion, each participant will be assessed one time only.
In the parents' questionnaires, previous contact with child welfare services will be recorded, along with the reason for the current involvement with child welfare services.
At inclusion, each participant will be assessed one time only.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Martin Forster, Karolinska Institutet

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

September 30, 2024

Primary Completion (Estimated)

September 30, 2025

Study Completion (Estimated)

September 30, 2025

Study Registration Dates

First Submitted

August 23, 2024

First Submitted That Met QC Criteria

August 23, 2024

First Posted (Actual)

August 27, 2024

Study Record Updates

Last Update Posted (Estimated)

September 19, 2024

Last Update Submitted That Met QC Criteria

September 16, 2024

Last Verified

September 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • Parent symptoms CWS

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Depression

Clinical Trials on Screening for depression and anxiety

Subscribe